| 6:45 a.m. |
Registration |
| 7:30 a.m. |
Introduction by Moderators |
| 7:35 a.m. |
2017 Harry Hirsch Leiter Award Recipient:
Grace Shih, MD
Diphtheroids as a corneal pathogen in chronic ocular surface disease
|
| 7:45 a.m. |
1. Evaluating the Antimicrobial Effect of Amniotic Membrane Grafts
Michele Lee, MD |
| 7:52 a.m. |
2. Is 2.5% (25mg/ml) Vancomycin the Same as 5% (50 mg/ml) in the Treatment of MRSA Keratitis?
Regis P. Kowalski |
| 7:59 a.m. |
3. Update on the Increasing Frequency of Sheen Isolates Among Pseudomonas aeruginosa Keratitis Isolates
Robert M.Q. Shanks, PhD |
| 8:06 a.m. |
4. A Multifunctional Bispecific Antibody Effective Against Pseudomonas Keratitis
Wesley Hebert, BSc |
| 8:13 a.m. |
5. Clinical Applications of Whole Metagenomic Shotgun DNA Sequencing for Diagnosis of Corneal Ulcers
Ilya M. Sluch, MD |
| 8:20 a.m. |
6. Development of a Novel Ophthalmic Antibiotic
Rachel Wozniak, MD, PhD |
| 8:27 a.m. |
7. A Contaminated Eye Care Solution Used to Prepare Corneal Donor Tissue and the Association with a Cluster of Corneal Rim Cultures Positive for Achromobacterspp
Joseph Ciolino, MD |
| 8:34 a.m. |
8. The Search For Antifungal Prophylaxis Following Artificial Cornea Surgery
Sarah Kim |
| 8:41 a.m. |
9. Optisol Supplemented with 0.255 mcg/ml Amphotericin B Does Not Eliminate Yeast at 5° C
Devin Tran, MD |
| 8:48 a.m. |
10. Understanding Fungal Virulence in Keratitis through a Reverse-Translational Approach
Kevin Fuller, MD |
| 8:55 a.m. |
11. Factors Associated with Acanthamoeba Keratitis Clearance Time
Todd Driver, MD |
| 9:02 a.m. |
12. In vitro Synergy Testing of Commonly Used Anti-amoebic Agents: Antagonism of Voriconazole
Jeremy Keenan, MD |
| 9:09 a.m. |
13. Resolution of Recurrent Acanthamoeba keratitis with Oral Miltefosine
Nikhil Dewan, MD |
| 9:16 a.m. |
BREAK |
| 9:35 a.m |
14. Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) as Adjunct Treatment for Infectious Keratitis
Jaime Martinez, MD |
| 9:42 a.m. |
15. Treatment of Corneal Ulcers with a Novel Far-UV SterilrayTM Wavelength (222nm) Lamp
J. James Rowsey, MD |
| 9:49 a.m. |
16. Impact of PDAT on S. aureus Inflammatory Response in an EpiCorneal Model
Alejandro Arboleda, MD |
| 9:56 a.m. |
17. Cellular and Molecular Assessment of Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) on Corneal Endothelium and Limbal Stem Cell Niche
Andrea Naranjo, MD |
| 10:03 a.m. |
18. Alpha-MSH Pretreatment Attenuates Corneal Endothelium Morphometric Changes in Eye Bank Stored Corneas in the Presence of Acute Oxidative Stress
Zala Luznik, MD, PhD |
| 10:10 a.m. |
19. Toxic Posterior Segment Syndrome following Dropless Cataract Surgery
Nikitha Reddy, MD |
| 10:17 a.m. |
20. Long-term Outcome of Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) for Delivery of Bevacizumab in the Treatment of Corneal Neovascularization
Jia Yin, MD, PhD |
| 10:24 a.m. |
21. Long-term Antimicrobial Silk-based Drug Delivery Implant for the Posterior Segment
Irmgard Behlau, MD |
| 10:31 a.m. |
22. Five-year Trends in Adenoviral Conjunctivitis in Employees of One Medical Center
Irene Kuo, MD |
| 10:38 a.m. |
23. Concomitant Herpetic Keratitis and Acute Retina Necrosis
Wendy Ming, MD |
| 10:45 a.m. |
24. Comparison of Post-Herpetic and Post-Refractive Surgery-Related Corneal Neuralgia
Mehmet Cuneyt Ozman, MD |
| 10:52 a.m. |
25. Associations Between Meibum Quality and Sphingolipid Quantity and Composition
Vikram Paranjpe, BS |
| 10:59 a.m. |
26. Dynamic Assessment of the Tear Film Muco-Aqueous and Lipid Layers Using a Novel Tear Film Imager (TFI)
Anat Galor, MD, MSPH |
| 11:06 a.m. |
27. Botulinum toxin A Improves Photophobia and Sensations of Dryness Independent of Ocular Surface Parameters
Jodi Hwang, BS |
| 11:13 a.m. |
28. Safety and Effiacy of Chronic Loteprednol Etabonate Gel Use for Dry Eye Disease
Neslihan Dilruba Koseoglu, MD |
| 11:20 a.m. |
BREAK |
| 11:30 a.m. |
Thygeson Lecture: Strategies to Induce Immune Tolerance for High Risk Corneal Transplants
Victor L. Perez, MD
Professor of Ophthalmology
Duke University School of Medicine, and
Director, Duke Eye Center for Ocular Immunology |
| 12:15 p.m. |
Closing Comments and Awards |
| 12:45 p.m. |
Business Luncheon -- Marquette Room |
